中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 38 Issue 11
Nov.  2022
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2022  >  38(11): 2470-2477

Evaluation of quality of life instruments for chronic diseases-chronic hepatitis(V2.0)based on classical test theory and item response theory

DOI: 10.3969/j.issn.1001-5256.2022.11.007

  • Department of Infection and Hepatology, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, China

Research funding:

National Natural Science Foundation of China (82160801);

Yunnan Provincial Department of Science and Technology-Kunming Medical University Basic Research Program (Kunming Medical Joint Special Project) (2018FE001(-214))

More Information
  • Corresponding author: LI Wu, liwukm@qq.com(ORCID: 0000-0002-1222-3629); CHEN Yihui, yihuichenyuan@sina.com(ORCID: 0000-0002-9896-6086)
  • Received Date: 2022-07-12
  • Accepted Date: 2022-08-15
  • Published Date: 2022-11-20
    Abstract
  •   Objective  Each item of the Chronic Hepatitis Quality of Life Scale (V2.0) was thoroughly analyzed and evaluated according to classical test theory (CTT) and item response theory (IRT).  Methods  The QLICD-CH (V2.0) scale was used to assess the life quality of 226 patients with chronic hepatitis who were hospitalized in the Department of Infectious Diseases from March 2019 to January 2020. By using CTT's coefficient of variation method, factor analysis method, Cronbach's alpha coefficient method and correlation coefficient method, macroscopic statistical analysis on the scale results was performed. IRT was used to microscopically analyze the information content, discrimination coefficient and difficulty parameters of each item.  Results  CTT analysis revealed that 36 items of the QLICD-CH (V2.0) scale satisfied three of the four statistical methods. IRT analysis showed that the average information content of 36 items was greater than 0.108, with the degree of discrimination ranging from -0.387 to 3.574; the degree of discrimination of 40 items was greater than 0.30; the difficulty coefficient of each item ranged from -14.805 to 9.057, with 31 items conformed to [-4, 4] and a monotonically increasing trend from b1 to b4.  Conclusion  The majority of items on the QLICD-CH (V2.0) scale perform well, but there are a few items that could be improved, optimized, or removed.

     

    • FullText(HTML)
  • loading
    • References(22)
  • [1]
    FOREMAN KJ, MARQUEZ N, DOLGERT A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories[J]. Lancet, 2018, 392(10159): 2052-2090. DOI: 10.1016/S0140-6736(18)31694-5.
    [2]
    CHUNG EK, ENQUOBAHRIE DA. Perinatal hepatitis B prevention: Eliminating disease and disparity[J]. Pediatrics, 2021, 147(3): e2020037549. DOI: 10.1542/peds.2020-037549.
    [3]
    Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Guidelines for the prevention and treatment of hepatitis C(2019 version)[J]. J Clin Hepatol, 2019, 35(12): 2670-2686. DOI: 10.3969/j.issn.1001-5256.2019.12.008.

    中华医学会肝病学分会, 中华医学会感染病学分会. 丙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2670-2686. DOI: 10.3969/j.issn.1001-5256.2019.12.008.
    [4]
    STANAWAY JD, FLAXMAN AD, NAGHAVI M, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013[J]. Lancet, 2016, 388(10049): 1081-1088. DOI: 10.1016/S0140-6736(16)30579-7.
    [5]
    YOUNOSSI ZM, TAMPI R, PRIYADARSHINI M, et al. Burden of illness and economic model for patients with nonalcoholic steatohepatitis in the United States[J]. Hepatology, 2019, 69(2): 564-572. DOI: 10.1002/hep.30254.
    [6]
    MIYASAKA A, YOSHIDA Y, SUZUKI A, et al. Health-related quality of life in patients with chronic hepatitis C treated with sofosbuvir-based treatment at 1-year post-sustained virological response[J]. Qual Life Res, 2021, 30(12): 3501-3509. DOI: 10.1007/s11136-021-02874-6
    [7]
    YOUNOSSI ZM, GOLABI P, HENRY L. A comprehensive review of patient-reported outcomes in patients with chronic liver diseases[J]. J Clin Gastroenterol, 2019, 53(5): 331-341. DOI: 10.1097/MCG.0000000000001179.
    [8]
    RAN XR, ZHANG TQ, CAI YF, et al. Analysis of the application of health-related quality of life scales in the field of chronic hepatitis based on bibliometrics[J]. Chin Gen Pract, 2018, 21(35): 4377-4382. DOI: 10.12114/j.issn.1007-9572.2018.00.105.

    冉雪蓉, 张堂钦, 蔡一凡, 等. 基于文献计量法分析健康相关生命质量量表在慢性肝炎领域中的应用[J]. 中国全科医学, 2018, 21(35): 4377-4382. DOI: 10.12114/j.issn.1007-9572.2018.00.105.
    [9]
    LI W, YANG SH, WANG CX, et al. Item selection in the development of QLICD-CH, a measure of quality of life in patients with chronic hepatitis[J]. Chin Gen Pract, 2010, 13(7): 722-724. DOI: 10.3969/j.issn.1007-9572.2010.07.012.

    李武, 杨善华, 王超秀, 等. 慢性肝炎患者生命质量测定量表QLICD-CH研制中的条目筛选[J]. 中国全科医学, 2010, 13(7): 722-724. DOI: 10.3969/j.issn.1007-9572.2010.07.012.
    [10]
    WANG CX, WAN CH, LI W, et al. Development and evaluation of quality of life measurement scale for patients with chronic hepatitis[J]. Chin Gen Pract, 2011, 14(31): 3562-3565. DOI: 10.3969/j.issn.1007-9572.2011.31.009.

    王超秀, 万崇华, 李武, 等. 慢性肝炎患者生命质量测定量表研制与考评[J]. 中国全科医学, 2011, 14(31): 3562-3565. DOI: 10.3969/j.issn.1007-9572.2011.31.009.
    [11]
    ZHUANG YZ, WAN CH, YANG Z, et al. Item analysis of drug addiction quality of life measurement scale QLICD-DA (V2.0) based on classical test theory and item response theory[J]. Mod Prevent Med, 2022, 49(5): 778-782. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYF202205003.htm

    庄云珠, 万崇华, 杨铮, 等. 基于经典测量理论与项目反应理论的药物成瘾生命质量测定量表QLICD-DA(V2.0)条目分析[J]. 现代预防医学, 2022, 49(5): 778-782. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYF202205003.htm
    [12]
    WU XY, YU L, WAN CH, et al. Item analysis of quality of life measurement scale for chronic gastritis QLICD-CG (V2.0) based on classical test theory and item response theory[J]. Mod Prevent Med, 2021, 48(19): 3626-3631. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYF202119037.htm

    巫小玉, 于磊, 万崇华, 等. 基于经典测量理论与项目反应理论的慢性胃炎生命质量测定量表QLICD-CG(V2.0)条目分析[J]. 现代预防医学, 2021, 48(19): 3626-3631. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYF202119037.htm
    [13]
    CHEN S, WAN CH, YANG Z, et al. Item analysis of breast cancer quality of life measurement scale QLICP-BR (V2.0) based on classical test theory and item response theory[J]. Chin J Health Statistics, 2021, 38(6): 864-869. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWT202106013.htm

    陈姝, 万崇华, 杨铮, 等. 基于经典测量理论与项目反应理论的乳腺癌生命质量测定量表QLICP-BR(V2.0)条目分析[J]. 中国卫生统计, 2021, 38(6): 864-869. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWT202106013.htm
    [14]
    EMBRETSON SE, REISE SP. Item response theory for psychologists[C]. Health Outcome Methodology Symposium, 2000.
    [15]
    WAN CH. Introductions on quality of life research: measurements·assessments·improvements[M]. Beijing: Science Press, 2016.

    万崇华. 生命质量研究导论: 测定·评价·提升[M]. 北京: 科学出版社, 2016.
    [16]
    FELDER S. Item response theory analysis of the Pain Self-Efficacy Questionnaire[J]. Scand J Pain, 2017, 14(1): 113-117. DOI: 10.1016/j.sjpain.2016.08.001.
    [17]
    FENGLING Y, FEI Z, YUN Z, et al. Modification and verification of the Infant-Toddler Meaningful Auditory Integration Scale: a psychometric analysis combining item response theory with classical test theory[J]. Health and quality of life outcomes, 2020, 18(1): 367. DOI: 10.1186/s12955-020-01620-9.
    [18]
    ZHANG CM, WAN CH, YANG Z, et al. Reliability analysis of patient-reported outcome scale for coronary heart disease[J]. Chin Gen Pract, 2019, 22(11): 1350-1354. DOI: 10.12114/j.issn.1007-9572.2018.00.209.

    张传猛, 万崇华, 杨铮, 等. 冠心病患者报告结局量表信度分析[J]. 中国全科医学, 2019, 22(11): 1350-1354. DOI: 10.12114/j.issn.1007-9572.2018.00.209.
    [19]
    LI JL, ZHAO YX, GU J, et al. Revised short form WHOQOL-BREF based on item response theory[J]. J Sun Yat-Sen Univ: Medical Sciences, 2015, 36(2): 284-293. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2015.0047.

    李佳玲, 赵艳霞, 顾菁, 等. 基于项目反应理论修订生存质量测定量表简表WHOQOL-BREF[J]. 中山大学学报(医学科学版), 2015, 36(2): 284-293. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2015.0047.
    [20]
    THOMAS ML. Advances in applications of item response theory to clinical assessment[J]. Psychol Assess, 2019, 31(12): 1442-1455. DOI: 10.1037/pas0000597.
    [21]
    HIGGINSON IJ, CARR AJ. Measuring quality of life: Using quality of life measures in the clinical setting[J]. BMJ, 2001, 322(7297): 1297-1300. DOI: 10.1136/bmj.322.7297.1297.
    [22]
    FAYERS R. Item response theory for psychologists by S. E. Embretson; S. Reise[J]. Qual Life Res, 2004, 13(3): 715-716. DOI: 10.2307/4038853.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(4)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (335) PDF downloads(40) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return